Studies will be conducted on hormonal and neural mechanisms which contribute to the etiology or exacerbation of hypertension and its sequelae. The focus of several units will be the renin-angiotensin system and studies will be conducted in the following areas: role of angiotensinogen in central mechanisms of blood pressure control and in hypertensive animals; relationship of adrenal corticosterone and mineralcorticoids to central angiotensin system; the role of angiotensin and neural pathways in controlling glomerular filtration and renovascular resistance; the dissociation of renin release and renal artery blood flow in the diving sea mammal and the role of the angiotensin system in salt and fresh water fishes. Changes in the mechanical state of arteries will be measured in vivo in hypertensive swine and correlated with alterations in hormonal state. The blood vessel in hypertension will be studied by several units using different approaches: studies of adrenergic receptor responsiveness will be quantified using receptor identification probes and the interaction between adrenergic and cholinergic receptors in blood vessels will be assessed. Prostaglandin biosynthetic pathways in the microvessels of the brain, retina, heart and kidney will be defined in normotensive and hypertensive animals which will permit the assessment of the role of prostaglandins in hypertension-mediated target organ damage. Central pathways important in blood pressure control will be defined both anatomically and by neurophysiologic methods in hypertensive animals, primates and man. The relationship of the kallikrein-kinin system to the state of sympathetic activity in man will be defined in ongoing clinical studies and the role of chronic antihypertensive therapy on these systems will be demonstrated. Ongoing clinical studies will overlap animal experimentation and the goal of all units will be to extend their findings in animals into unique clinical investigations in man. The mechanisms inherent in SCOR will make this possible during the tenure of the grant.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL025457-05
Application #
3106609
Study Section
(SRC)
Project Start
1980-09-01
Project End
1986-03-31
Budget Start
1984-12-01
Budget End
1986-03-31
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Powers, R E; O'Connor, D T; Price, D L (1990) Noradrenergic innervation of human inferior olivary complex. Brain Res 523:151-5
Toranji, S; Brown, R D (1989) Temporal integration of alpha 1-adrenergic responses in BC3H-1 muscle cells. Regulation of glycogen phosphorylase activity. J Biol Chem 264:11558-64
Parmer, R J; O'Connor, D T (1988) Enkephalins in human phaeochromocytomas: localization in immunoreactive, high molecular weight form to the soluble core of chromaffin granules. J Hypertens 6:187-98
Blantz, R C; Gabbai, F B (1987) Effect of angiotensin II on glomerular hemodynamics and ultrafiltration coefficient. Kidney Int Suppl 20:S108-11
Wilner, K D; Ziegler, M G (1987) Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension. Am J Cardiol 59:82G-86G
O'Connor, D T; Strause, L; Saltman, P et al. (1987) Serum zinc is unaffected by effective captopril treatment of hypertension. J Clin Hypertens 3:405-8
Gerstberger, R; Healy, D P; Hammel, H T et al. (1987) Autoradiographic localization and characterization of circumventricular angiotensin II receptors in duck brain. Brain Res 400:165-70
Blantz, R C (1987) The glomerular and tubular actions of angiotensin II. Am J Kidney Dis 10:2-6
Kennedy, B; Strassman, R J; Ziegler, M G et al. (1987) Cardiovascular, catecholamine and psychological responses to TRH in four types of affective disorder patients. Horm Metab Res 19:164-7
Brown, R D; Berger, K D; Taylor, P (1987) The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells. Mol Pharmacol 32:43-52

Showing the most recent 10 out of 40 publications